• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

SR146131

CAS No. 221671-61-0

SR146131 ( SR-146131 | SR 146131 )

产品货号. M13535 CAS No. 221671-61-0

SR146131 (SR-146131) 一种 1 型胆囊收缩素受体 (CCK1R) 的小分子正变构调节剂,pEC50 为 10.34。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
10MG ¥5654 有现货
25MG ¥12393 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    SR146131
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    SR146131 (SR-146131) 一种 1 型胆囊收缩素受体 (CCK1R) 的小分子正变构调节剂,pEC50 为 10.34。
  • 产品描述
    SR146131 (SR-146131) a small molecule positive allosteric modulator of the type 1 cholecystokinin receptor (CCK1R) with pEC50 of 10.34.
  • 体外实验
    SR 146131 inhibits in the binding of [125I]-BH-CCK-8S to CCK1sites on 3T3-hCCK1 cell membranes with an IC50 value of 0.56 ± 0.10 nM. At much higher concentrations, SR 146131 also inhibits the binding of radiolabeled CCK to CCK2sites in CHO-hCCK2 membranes with an IC50 of 162 ± 27 nM. SR 146131 is a potent CCK1 agonist on several intracellular events linked to CCK1 receptor activation in various cell types: on [Ca2+]i release and IP1 formation, SR 146131 appears as a full CCK1 receptor agonist in the 3T3-hCCK1 cells, but a partial CCK1receptor agonist on MAPK activation and early gene expression in this cell line. SR 146131 also acts as a partial agonist in the two neuroblastoma cell lines.
  • 体内实验
    SR 146131 completely inhibits gastric and gallbladder emptying in mice (ED50 of 66 and 2.7 μg/kg p.o., respectively). SR 146131 dose dependently reduces food intake in fasted rats (from 0.1 mg/kg p.o.), in nonfasted rats in which food intake has been highly stimulated by the administration of neuropeptide Y (1–36) (from 0.3 mg/kg p.o.), in fasted gerbils (from 0.1 mg/kg p.o.), and in marmosets maintained on a restricted diet (from 3 mg/kg p.o.). SR 146131 (10 mg/kg p.o.) also increases the number of Fos-positive cells in the hypothalamic paraventricular nucleus of rats. Locomotor activity of mice is reduced by orally administered SR 146131 (from 0.3 mg/kg p.o.).
  • 同义词
    SR-146131 | SR 146131
  • 通路
    GPCR/G Protein
  • 靶点
    Cholecystokinin Receptor
  • 受体
    Cholecystokinin Receptor
  • 研究领域
    Metabolic Disease
  • 适应症
    ——

化学信息

  • CAS Number
    221671-61-0
  • 分子量
    610.166
  • 分子式
    C32H36ClN3O5S
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 250 mg/mL (409.73 mM)
  • SMILES
    O=C(O)CN1C(C(NC2=NC(C3=CC(OC)=C(Cl)C=C3OC)=C(CCC4CCCCC4)S2)=O)=CC5=C1C(C)=CC(C)=C5
  • 化学全称
    2-(2-((4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)thiazol-2-yl)carbamoyl)-5,7-dimethyl-1H-indol-1-yl)acetic acid

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Desai AJ, et al. Mol Pharmacol. 2018 Dec 27. pii: mol.118.114082. doi: 10.1124/mol.118.114082.
产品手册
关联产品
  • L-365260

    一种有效的、选择性的、口服活性的胆囊收缩素受体 2 (CCK2) 拮抗剂,IC50 为 2 nM。

  • Methyl Linoleate

    亚油酸甲酯具有抗氧化活性。

  • Lorglumide sodium sa...

    Lorglumideodium salt 是一种有效的胆囊收缩素 (CCK) 受体拮抗剂。